Martin Hochheimer

Also affiliated with Johns Hopkins Medicine, Behavioral Pharma (United States)

MedicinePsychologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Transgender individuals are at higher risk for suicidal ideation and preparation than cisgender individuals in substance use treatment”.

Transgender individuals are at higher risk for suicidal ideation and preparation than cisgender individuals in substance use treatment

Frontiers in Psychiatry(2023)10.3389/fpsyt.2023.1225673

N/A

0DataRank · unranked

8 citations

Jennifer L. Glick, Henri M. Garrison‐Desany, Andrew S. Huhn, Martin Hochheimer

Patterns of demoralization and anhedonia during early substance use disorder treatment and associations with treatment attrition

Journal of Affective Disorders(2023)10.1016/j.jad.2023.05.029

N/A

0DataRank · unranked

6 citations

Jennifer D. Ellis, Justin C. Strickland, Martin Hochheimer, Yijun Zhou, Andrea S. Young +3 more

A systematic review of latent class analyses of adult polysubstance use patterns.

Experimental and Clinical Psychopharmacology(2025)10.1037/pha0000791

N/A

0DataRank · unranked

4 citations

Neha Skandan, Martin Hochheimer, Emma Pattillo, Jacob White, Andrew S. Huhn +2 more